Cynomolgus LILRB4/CD85k/ILT3 Protein, Accession: XP_015297198

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Cynomolgus LILRB4/CD85k/ILT3 Protein Protein is expressed from HEK293 with His tag at the C-terminal.It contains Gln22-Glu259.

    Biotinylated

    产物规格

    靶点

    LILRB4/CD85k/ILT3

    份子又名

    HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K

    Accession

    种属

    Cynomolgus

    卵白序列

    Gln22-Glu259

    份子量

    The protein has a predicted MW of 27.2 kDa. Due to glycosylation, the protein migrates to 35-42 kDa based on Tris-Bis PAGE result.

    活性

    Immobilized Cynomolgus LILRB4, His Tag at 5ug/ml (100ul/well) on the plate. Dose response curve for Anti-LILRB4 Antibody, hFc Tag with the EC50 of 0.38ug/ml determined by ELISA. See testing image for detail.

    产物标签

    C-His

    抒发体系

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Lyophilized

    运输前提

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和不变性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 该副产物的企业ChemWhat是Watson的注册公司品牌，由Watson受权河南海角社区 在国内 中国香港温带季风气候合理利用，点此拜候。